Improved glycemic control in pancreatic diabetes through intensive conservative insulin therapy

Pancreatology

Volumn 12, Issue 2, 2012, Pages 100-103

  Terzin, Viktória ^a   Takács, Róbert ^a   Lengyel, Csaba ^a   Várkonyi, Tamás ^a   Wittmann, Tibor ^a   Pálinkás, Attila ^b   Czakó, László ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b Erzsebet Hospital   (Hungary)

Author keywords

Chronic pancreatitis; Glycemic control; Insulin; Oral antidiabetic medication; Pancreatic diabetes; Pancreatic enzyme replacement

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

ADULT; AGED; ARTICLE; CHRONIC PANCREATITIS; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFICACY; DRUG SAFETY; FEMALE; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN TREATMENT; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 84862230376     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1016/j.pan.2012.01.004     Document Type: Article

References (26)

1. Owyang C. Endocrine changes in pancreatic insufficiency. In: Go VLW, Di Magno EP, editors. The pancreas: biology, pathobiology and diseases. New York: Raven Press; 1993. p. 803-13.
2. Angelopoulos N, Dervenis C, Goula A, Rombopoulos G, Livadas S, Kaltsas D, et al. Endocrine pancreatic insufficiency in chronic pancreatitis. Pancreatology 2005;5:122-31. (Pubitemid 40754729)
3. Czakó L, Hegyi P, Rakonczay Z, Wittmann T, Otsuki M. Interactions between the endocrine and exocrine pancreas and its clinical relevance. Pancreatology 2009;9:351-9.
4. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2007;30:S42-7.
5. Ito T, Otsuki M, Igarashi H, Kihara Y, Kawabe K, Nakamura T, et al. Epidemiological study of pancreatic diabetes in Japan in 2005. A nationwide study. Pancreas 2010;39:829-35.
6. Malka D, Hammel P, Sauvanet A, Rufat P, O'Toole D, Bardet P, et al. Risk factors of diabetes mellitus in chronic pancreatitis. Gastroenterology 2000;119: 1324-32.
7. Mohan V, Barman KK, Rajan VS, Chari ST, Deepa R. Natural history of endocrine failure in tropical chronic pancreatitis: a longitudinal follow-up study. J Gastroenterol Hepatol 2005;20:1927-34. (Pubitemid 43961052)
8. Hardt PD, Brendel MD, Kloer HU, Bretzel RG. Is pancreatic diabetes (type 3c diabetes) underdiagnosed and misdiagnosed? Diabetes Care 2008;31(Suppl. 2):S165-9.
9. Ewald N, Kaufmann C, Raspe A, Kloer HU, Bretzel RG, Hardt PD. Prevalence of diabetes mellitus secondary to pancreatic diseases (type 3c). Diabetes Metab Res Rev; 2011 Nov 26:2260. doi:10.1002/dmrr [Epub ahead of print].
10. Donowitz M, Hendler R, Spiro HM, Binder HJ, Felig P. Glucagon secretion in acute and chronic pancreatitis. Ann Intern Med 1975;83:778-81.
11. Valenzuela JE, Taylor IL, Walsh JH. Pancreatic polypeptide response in patients with chronic pancreatitis. Dig Dis Sci 1979;24:862-4. (Pubitemid 10217947)
12. Govindarajan M, Mohan V, Deepa R, Ashok S, Pitchumoni CS. Histopathology and immunohistochemistry of pancreatic islets in fibrocalculous pancreatic diabetes. Diabetes Res Clin Pract 2001;51:29-38. (Pubitemid 32008449)
13. Andersen DK. Mechanisms and emerging treatments of the metabolic complications of chronic pancreatitis. Pancreas 2007;35:1-15. (Pubitemid 46956195)
14. Price S, Cole D, Alcolado JC. Diabetes due to exocrine pancreatic disease - a review of patients attending a hospital-based diabetes clinic. Q J Med 2010; 103:759-63.
15. Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R, et al. Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the study of diabetes. Diabetologia 2009;52:17-30.
16. European Diabetes Policy Group. A desktop guide to type 1 (insulin-dependent) diabetes mellitus. Diab Med 1998;1999(16):253-66.
17. DiMagno MJ, DiMagno EP. Chronic pancreatitis. Curr Opin Gastroenterol 2010; 26:490-8.
18. Choudhuri G, Lakshmi CP, Goel A. Pancreatic diabetes. Trop Gastroenterol 2009;30:71-5.
19. Cui Y, Andersen DK. Pancreatogenic diabetes: special considerations for management. Pancreatol 2011;11:279-94.
20. Satoh J, Takahashi K, Takizawa Y, Ishihara H, Hirai M, Katagiri H, et al. Secondary sulfonylurea failure: comparison of period until insulin treatment between diabetic patients treated with gliclazide and glibenclamide. Diabetes Res Clin Pract 2005;70:291-7. (Pubitemid 41539792)
21. Cavallini G, Vaona B, Bovo P, Cigolini M, Rigo L, Rossi F. Diabetes in chronic alcoholic pancreatitis. Role of residual beta cell function and insulin resistance. Dig Dis Sci 1993;38:497-501. (Pubitemid 23087125)
22. Sjoberg RJ, Kidd GS. Pancreatic diabetes mellitus. Diabetes Care 1989;12: 715-24. (Pubitemid 19284095)
23. Miura J, Yokoyama J, Miura A, Mori Y, Ito K, Ikeda Y. Clinical efficacy of multiple insulin injection regimen in pancreatogenic diabetes (in Japanese). J Jpn Diabet Soc 1991;34:685-91.
24. Gerö LA. Pancreatogen diabetes okai, tünettana és kezelése. Diabetologia Hungarica 2002;10(Suppl. 3):19-22.
25. Kawabe K, Ito T, Igarashi H, Takayanagi R. The current managements of pancreatic diabetes in Japan. Clin J Gastroenterol 2009;2:1-8.
26. Starke AAR, Cupers HJ, Berger M. Therapeutic problems in diabetes secondary to pancreopathy. In: Tiengo A, Alberti KGMM, Del Prato S, Vranic M, editors. Diabetes secondary to pancreopathy. Amsterdam: Excerpta Medica; 1988. p. 227-33.